165 related articles for article (PubMed ID: 1659231)
1. Kappa-opioid peptide receptor stimulation increases cytosolic pH and myofilament responsiveness to Ca2+ in cardiac myocytes.
Ventura C; Capogrossi MC; Spurgeon HA; Lakatta EG
Am J Physiol; 1991 Nov; 261(5 Pt 2):H1671-4. PubMed ID: 1659231
[TBL] [Abstract][Full Text] [Related]
2. Kappa and delta opioid receptor stimulation affects cardiac myocyte function and Ca2+ release from an intracellular pool in myocytes and neurons.
Ventura C; Spurgeon H; Lakatta EG; Guarnieri C; Capogrossi MC
Circ Res; 1992 Jan; 70(1):66-81. PubMed ID: 1309318
[TBL] [Abstract][Full Text] [Related]
3. Acidosis antagonizes intracellular calcium response to kappa-opioid receptor stimulation in the rat heart.
Pei JM; Yu XC; Bian JS; Wong TM
Am J Physiol; 1999 Sep; 277(3):C492-500. PubMed ID: 10484336
[TBL] [Abstract][Full Text] [Related]
4. Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
Scheurer U; Wenger F; Caliezi A; Drack E; Varga L; Halter F
J Pharmacol Exp Ther; 1990 Mar; 252(3):1324-30. PubMed ID: 1969475
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade.
Pugsley MK; Penz WP; Walker MJ; Wong TM
Br J Pharmacol; 1992 Mar; 105(3):521-6. PubMed ID: 1320979
[TBL] [Abstract][Full Text] [Related]
6. kappa -opioid receptor stimulation induces arrhythmia in the isolated rat heart via the protein kinase C/Na(+)-H(+)exchange pathway.
Bian JS; Pei JM; Cheung CS; Zhang WM; Wong TM
J Mol Cell Cardiol; 2000 Aug; 32(8):1415-27. PubMed ID: 10900168
[TBL] [Abstract][Full Text] [Related]
7. kappa-Opioid receptor stimulation increases intracellular free calcium in isolated rat ventricular myocytes.
Tai KK; Bian CF; Wong TM
Life Sci; 1992; 51(12):909-13. PubMed ID: 1355576
[TBL] [Abstract][Full Text] [Related]
8. Different effects of alpha- and beta-adrenergic stimulation on cytosolic pH and myofilament responsiveness to Ca2+ in cardiac myocytes.
Gambassi G; Spurgeon HA; Lakatta EG; Blank PS; Capogrossi MC
Circ Res; 1992 Oct; 71(4):870-82. PubMed ID: 1516160
[TBL] [Abstract][Full Text] [Related]
9. Pertussis toxin, but not tyrosine kinase inhibitors, abolishes effects of U-50488H on [Ca2+]i in myocytes.
Sheng JZ; Wong NS; Wang HX; Wong TM
Am J Physiol; 1997 Feb; 272(2 Pt 1):C560-4. PubMed ID: 9124299
[TBL] [Abstract][Full Text] [Related]
10. Hyperalgesic effect of the selective kappa opioid agonist, U-50488H in mice.
Ramabadran K
Jpn J Pharmacol; 1983 Dec; 33(6):1289-92. PubMed ID: 6321836
[No Abstract] [Full Text] [Related]
11. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.
Wilson JL; Nayanar V; Walker JS
Br J Pharmacol; 1996 Aug; 118(7):1754-60. PubMed ID: 8842441
[TBL] [Abstract][Full Text] [Related]
12. Anti-arrhythmic effect of kappa-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway.
Yu XC; Wang HX; Pei JM; Wong TM
J Mol Cell Cardiol; 1999 Oct; 31(10):1809-19. PubMed ID: 10525419
[TBL] [Abstract][Full Text] [Related]
13. Effects of kappa-opioid receptor stimulation in the heart and the involvement of protein kinase C.
Bian JS; Wang HX; Zhang WM; Wong TM
Br J Pharmacol; 1998 Jun; 124(3):600-6. PubMed ID: 9647487
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and functional interactions of a selective kappa opioid agonist with calcium.
VonVoigtlander PF; Ochoa MC; Lewis RA
Adv Exp Med Biol; 1987; 221():345-55. PubMed ID: 2829584
[TBL] [Abstract][Full Text] [Related]
15. The specific opioid kappa-agonist U-50,488H inhibits low Km GTPase.
Ueda H; Misawa H; Fukushima N; Takagi H
Eur J Pharmacol; 1987 Jun; 138(1):129-32. PubMed ID: 3040426
[TBL] [Abstract][Full Text] [Related]
16. Pertussis and cholera toxins modulate kappa-opioid receptor agonists-induced hypothermia and gut inhibition.
Shukla VK; Turndorf H; Bansinath M
Eur J Pharmacol; 1995 Mar; 292(3-4):293-9. PubMed ID: 7796869
[TBL] [Abstract][Full Text] [Related]
17. In vitro depressant effects of U-54494A, an anticonvulsant related to kappa opioids, in the hippocampus.
Proietti ML; Scotti de Carolis A; Frank C; Zeng YC; Sagratella S
Neuropharmacology; 1991 Jun; 30(6):637-42. PubMed ID: 1656303
[TBL] [Abstract][Full Text] [Related]
18. Distinct components of morphine effects on cardiac myocytes are mediated by the kappa and delta opioid receptors.
Ela C; Barg J; Vogel Z; Hasin Y; Eilam Y
J Mol Cell Cardiol; 1997 Feb; 29(2):711-20. PubMed ID: 9140828
[TBL] [Abstract][Full Text] [Related]
19. Differential antagonism of bremazocine- and U69,593-induced antinociception by quadazocine: further functional evidence of opioid kappa receptor multiplicity in the mouse.
Horan PJ; de Costa BR; Rice K; Haaseth RC; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 1993 Aug; 266(2):926-33. PubMed ID: 8394923
[TBL] [Abstract][Full Text] [Related]
20. Intracerebroventricular administration of kappa-agonists induces convulsions in mice.
Bansinath M; Ramabadran K; Turndorf H; Shukla VK
Brain Res Bull; 1991 Jul; 27(1):75-9. PubMed ID: 1657321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
